Optimistic Buy Rating for Arcturus Therapeutics Amid Strong Kostaive Vaccine Market Prospects in Japan
TipRanksMar 26 19:15
Arcturus Therapeutics Analyst Ratings
BenzingaMar 20 18:42
HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $60 Price Target
BenzingaMar 20 18:44
Arcturus Therapeutics Analyst Ratings
BenzingaMar 11 19:50
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)
TipRanksMar 11 12:40
Arcturus Therapeutics (ARCT) Gets a Buy From Piper Sandler
TipRanksMar 8 20:46
Arcturus Therapeutics Analyst Ratings
BenzingaMar 8 20:48
Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Arcturus Therapeutics (ARCT)
TipRanksMar 8 18:50
Citigroup Maintains Buy on Arcturus Therapeutics, Raises Price Target to $48
BenzingaFeb 9 00:04
Arcturus Therapeutics Analyst Ratings
BenzingaFeb 9 00:03
Analysts Conflicted on These Healthcare Names: McKesson (MCK), Arcturus Therapeutics (ARCT) and Neurocrine (NBIX)
TipRanksFeb 8 19:02
Buy Rating for Arcturus Therapeutics Amid Promising Vaccine Developments and Cost Advantages
TipRanksJan 13 23:15
Piper Sandler Remains a Buy on Arcturus Therapeutics (ARCT)
TipRanksJan 10 20:18
Arcturus Therapeutics Analyst Ratings
BenzingaDec 13, 2023 17:34
Buy Rating for Arcturus Therapeutics: ARCT-154's Global Regulatory Success and Market Potential
TipRanksNov 29, 2023 18:19
HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target
BenzingaNov 28, 2023 20:22
Arcturus Therapeutics Analyst Ratings
BenzingaNov 28, 2023 20:21
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Alcon (ALC)
TipRanksNov 16, 2023 18:50
HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target
BenzingaNov 15, 2023 23:37
Arcturus Therapeutics Analyst Ratings
BenzingaNov 15, 2023 23:34
No Data
No Data